SCHEMBL25515352

SCHEMBL25515352

CNCC(=O)c1ccc2ccccn12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
KDM4E B2RXH2 5/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 5/20 0.35
HTT P42858 1/20 0.35
ATM Q13315 1/20 0.35
THRB P10828 1/20 0.35
ALDH1A1 P00352 6/20 0.33
KMT2A Q03164 3/20 0.33
GAA P10253 3/20 0.33
MEN1 O00255 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
RECQL P46063 1/20 0.33
BAZ2B Q9UIF8 3/20 0.33
BAZ2A Q9UIF9 3/20 0.33
MAPK1 P28482 2/20 0.33
ALOX12 P18054 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31183049 0.89 MAPT (0.34) MAPTKDM4ERAB9APOLBALDH1A1
SCHEMBL6248007 0.81 L3MBTL1 (0.40) MAPTKDM4ERAB9ASMN1; SMN2POLB
SCHEMBL31183044 0.78 PTGS2 (0.35) MAPTKDM4ERAB9ASMN1; SMN2L3MBTL1
SCHEMBL25515348 0.78 PTPN1 (0.42) MAPTKDM4ERAB9ASMN1; SMN2L3MBTL1
SCHEMBL30147703 0.78 KDM4E (0.41) MAPTKDM4ERAB9ASMN1; SMN2POLB
SCHEMBL6276005 0.76 HSD17B3 (0.40) MAPTL3MBTL1HTTATMALDH1A1
SCHEMBL6535007 0.75 ALDH1A1 (0.45) MAPTKDM4ERAB9ASMN1; SMN2L3MBTL1
SCHEMBL25515640 0.75 MAPT (0.48) MAPTKDM4ERAB9ASMN1; SMN2POLB
SCHEMBL25510901 0.74 KDM4E (0.35) MAPTKDM4ERAB9ASMN1; SMN2POLB
SCHEMBL25515107 0.73 THRB (0.37) MAPTKDM4ERAB9ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081306-A1 INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT TACTOGEN INC (US) 2023-05-11 WO disclosed